74 – 4. CURRENT HIGH-VISIBILITY INDUSTRIAL BIOTECHNOLOGY PRODUCTS
FUTURE PROSPECTS FOR INDUSTRIAL BIOTECHNOLOGY – © OECD 2011
It has often been said that one of the difficulties facing industrial
biotechnology is a lack of investors, both public and private. Compared to
pharmaceutical biotechnology, industrial biotechnology lacks visibility: its
products, and their value, are less clearly perceived. However, research in
and commercialisation of industrial biotechnology have made good progress
in recent years. This chapter aims to illustrate some major successes, but
also to point to the breadth and variety of industrial biotechnology’s future
prospects. It is not meant to be exhaustive.
The biofuels sector has already had plenty of exposure and so will be
discussed relatively little here. Very recent developments in US legislation
(see Chapter 3) seem to make the future of biofuels a near certainty.
Equally, the biochemicals sector is well established at full scale and will
also receive less attention. In particular, production of amino acids and
vitamins by fermentation routes are a major industry in its own right, and
there are no serious synthetic routes for most of these products. Instead, the
chapter concentrates on products that have a petrochemical route to
production, but can be replaced by biological routes which are potentially
easier to make, use less energy and water, produce less waste and have
lower greenhouse gas (GHG) emissions.
For the bioplastics sector, the second largest renewable sector after
biofuels, framework conditions – both legal and market – play a significant
role in the market introduction phase. Unlike the renewable energy and
biofuels sectors, this sector lacks supportive framework conditions. In
individual EU countries the first initiatives to facilitate the introduction of
bioplastics are however emerging.
Industrial biotechnology penetrates the thermoplastics market
Ethylene is the organic compound most produced in the world; in 2005
the combined US and European production exceeded 45 million tonnes
(Chemical and Engineering News, 2006). The most obvious route to
ethylene in a bioprocess is the conversion of bioethanol to ethylene via (non-
biological) dehydration of bioethanol. This can be carried out using a range
of catalysts and there are no technological hurdles to overcome. The
question is price, specifically the availability of cheap sugar for fermentation
to ethanol. This means that Brazil, with its long history of cane sugar
bioethanol production, is likely to be the initial producing country.
The Brazilian petrochemicals and polymers group Braskem started to
supply its first bio-based polyethylene (PE) products in 2010 (Smith, 2010).
Braskem claims that the production of every tonne of its bio-based PE
captures 2.5 tonnes of CO
2
; the traditional petrochemical route results in
emissions of close to 3.5 tonnes. However, it should be noted that there is no